Skip Navigation

Faculty Directory

Richard E. Chaisson, MD

Director, Center for TB Research, Principal Investigator, Center for AIDS Research

Professor

Departmental Affiliation(s):

School of Medicine (Primary)
Epidemiology (Joint)
Division: Infectious Disease Epidemiology
International Health (Joint)

Center & Institute Affiliation(s):

Contact Information

1550 Orleans St., Room 1M.08
Baltimore , Maryland   21231
US        

410-955-1755
410-955-0740

Personal website : http://www.tbhiv-create.org/

SciVal Experts Research Profile

Education

MD

Overview

Richard E. Chaisson, M.D., is Professor of Medicine, Epidemiology and International Health and Director of the Johns Hopkins University Center for Tuberculosis Research and Principal Investigator of the Hopkins Center for AIDS Research (CFAR). The Center for Tuberculosis Research is a multidisciplinary research and training center with more than $180 million in grants for the study of TB from bench to bedside.  The new CFAR is a $16 million program to promote interdisciplinary HIV research, support new investigators and address the Baltimore HIV epidemic.

Dr. Chaisson's research interests focus on tuberculosis and HIV infection, including global epidemiology and control, prevention, clinical trials, and public health interventions. He is currently principal investigator of 11 research grants, and is principal investigator of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), an international research consortium funded by the Bill and Melinda Gates Foundation to assess the impact of novel strategies for controlling HIV-related TB. He has published over 380 scientific papers and book chapters.

Honors and Awards

World Lung Health Award, American Thoracic Society, 2006

Tuberculosis, HIV, Infectious Diseases

  • Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B.  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.  AIDS. 2007;21:1441-8.

  • Martinson NA, Karstaedt A, Venter WD, Omar T, King P, Mbengo T, Marais E, McIntyre J, Chaisson RE, Hale M.  Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study.  AIDS.  2007;21:2043-50.

  • Rosenthal IM, Zhang M, Williams KN, Peloquin CA, Tyagi S, Vernon AA, Bishai WR, Chaisson RE, Grosset JH, Nuermberger EL.  Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model.PLoS Med. 2007 Dec 18;4(12):e344.

  • Hoffmann CJ, Fielding KL, Charalambous S, Sulkowski MS, Innes C, Thio CL, Chaisson RE, Churchyard GJ, Grant AD.  Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS. 2008 Jan 2;22(1):67-74.

  • Pemba L, Charalambous S, von Gottberg A, Magadla B, Moloi V, Seabi O, Wasas A, Klugman KP, Chaisson RE, Fielding K, Churchyard GJ, Grant AD.   Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus